Gross WL - Search Results

1

[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].

Schnabel A, Csernok E, Schultz H, Stoffel M, Herzberg C, Carroll SF, Gross WL. Schnabel A, et al. Among authors: gross wl. Med Klin (Munich). 1997 Jul 15;92(7):389-93. doi: 10.1007/BF03042568. Med Klin (Munich). 1997. PMID: 9324622 German.

2

Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.

Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL. Stoffel MP, et al. Among authors: gross wl. Clin Exp Immunol. 1996 Apr;104(1):54-9. doi: 10.1046/j.1365-2249.1996.d01-654.x. Clin Exp Immunol. 1996. PMID: 8603534 Free PMC article.

3

Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.

Schultz H, Csernok E, Johnston TW, Lockwood CM, Gross WL. Schultz H, et al. Among authors: gross wl. J Immunol Methods. 1997 Jul 14;205(2):127-33. doi: 10.1016/s0022-1759(97)00067-7. J Immunol Methods. 1997. PMID: 9294593

4

New perspectives in pulmonary angiitis. From pulmonary angiitis and granulomatosis to ANCA associated vasculitis.

Gross WL, Schnabel A, Trabandt A. Gross WL, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Mar;17(1):33-52. Sarcoidosis Vasc Diffuse Lung Dis. 2000. PMID: 10746260 Review.

5

Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.

Schultz H, Csernok E, Schuster A, Schmitz TS, Ernst M, Gross WL. Schultz H, et al. Among authors: gross wl. Pediatr Allergy Immunol. 2000 May;11(2):64-70. doi: 10.1034/j.1399-3038.2000.00069.x. Pediatr Allergy Immunol. 2000. PMID: 10893006

6

BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule.

Schultz H, Csernok E, Nikkari S, Toivanen P, Toivanen A, Gross WL. Schultz H, et al. Among authors: gross wl. Scand J Rheumatol. 2000;29(4):226-31. doi: 10.1080/030097400750041361. Scand J Rheumatol. 2000. PMID: 11028843

7

The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.

Schultz H, Weiss J, Carroll SF, Gross WL. Schultz H, et al. Among authors: gross wl. J Leukoc Biol. 2001 Apr;69(4):505-12. J Leukoc Biol. 2001. PMID: 11310835 Review.

8

ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.

Schultz H, Csernok E, Herlyn K, Reichel PH, Moosig F, Cornely OA, Fagerhol MK, Gross WL. Schultz H, et al. Among authors: gross wl. Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S117-20. Clin Exp Rheumatol. 2003. PMID: 14740437

9

Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.

Gross WL, Csernok E. Gross WL, et al. Curr Opin Rheumatol. 1995 Jan;7(1):11-9. Curr Opin Rheumatol. 1995. PMID: 7718417 Review.

10

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.

Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Schnabel A, et al. Among authors: gross wl. Arthritis Rheum. 1995 May;38(5):633-7. doi: 10.1002/art.1780380509. Arthritis Rheum. 1995. PMID: 7748219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters